What is the recommended intravenous lignocaine (lidocaine) dose, timing, and precautions for use during endotracheal intubation?

Intravenous Lidocaine During Intubation

For endotracheal intubation, administer 1.5 mg/kg of intravenous lidocaine over 10 minutes, completing the infusion 1-3 minutes before laryngoscopy to optimally blunt hemodynamic responses, cough reflexes, and increases in intracranial/intraocular pressure.

Dosing Recommendations

The evidence strongly supports a specific dosing protocol:

• Standard dose: 1.5 mg/kg IV 1
• Timing: Administer 1-3 minutes before intubation for optimal effect 2, 3, 4
• Infusion rate: Give over 10 minutes when used as part of anesthetic induction 1
• Alternative rapid dosing: For emergency intubation, 1-2 mg/kg can be given as a bolus 30 seconds to 5 minutes before airway instrumentation 5

The 2021 international consensus on IV lidocaine emphasizes that too rapid an infusion increases toxicity risk 1. Research demonstrates dose-dependent efficacy: 1.5 mg/kg provides superior cough suppression (NNT=5) compared to lower doses, while 2 mg/kg achieves complete suppression (NNT=3) 6.

Timing Considerations

The optimal window is 1-3 minutes before laryngoscopy 4. Studies show:

• At 1 minute: Effective for IOP and blood pressure attenuation 4
• At 3 minutes: Maximum cardiovascular stability and IOP control 3, 4
• Beyond 5 minutes: Efficacy diminishes 4

For emergency situations where rapid sequence intubation is needed, the dose can be given 30 seconds before intubation, though this is less optimal 5.

Weight-Based Calculations

Use ideal body weight, not actual body weight 1:

• Men: height (cm) - 100 = ideal body weight (kg)
• Women: height (cm) - 105 = ideal body weight (kg)
• If BMI <30 kg/m², actual and ideal weights are similar

Do not use in patients <40 kg 1.

Pediatric Dosing

For children:

• Standard dose: 1-2 mg/kg IV 5, 7
• Maximum: 3 mg/kg cumulative dose 8, 5
• Reduce doses by 30% in infants <6 months 9

Maximum Safe Doses

Critical safety thresholds to prevent toxicity:

Adults:

• Single dose maximum: 300 mg or 4.5 mg/kg (whichever is lower) 10
• Toxic plasma levels occur >5 μg/mL 1, 8

Children:

• Without epinephrine: 4.5 mg/kg maximum 9, 10
• With epinephrine: 7 mg/kg maximum 9

Monitoring Requirements

Mandatory monitoring during administration 1:

• Continuous ECG
• Continuous pulse oximetry
• Blood pressure every 5 minutes during infusion and for 15 minutes after
• An anesthetist must be present during initial dosing

Clinical Benefits

Lidocaine at 1.5 mg/kg administered before intubation provides:

• Cough suppression: Dose-dependent reduction with near-complete suppression at higher doses 11, 6
• Hemodynamic stability: Blunts blood pressure surges by 19% compared to placebo 3
• ICP protection: Prevents intracranial pressure increases during laryngoscopy 2, 4
• IOP protection: Attenuates intraocular pressure rises 4
• Dysrhythmia prevention: Reduces intubation-related arrhythmias 2

High-Risk Populations Requiring Caution

Reduce doses or avoid in:

• Severe hepatic disease (impaired metabolism) 10
• Congestive heart failure (increased cardiac toxicity risk) 12, 10
• Heart block (contraindicated in complete heart block) 5
• Elderly patients (reduce dose) 10
• Severe shock (use with caution) 10

Toxicity Recognition and Management

Early warning signs (plasma levels 5-10 μg/mL) 1:

• Tingling tongue/lips
• Light-headedness
• Tinnitus
• Slurred speech
• Euphoria or facial flushing

Severe toxicity (plasma levels >10 μg/mL):

• Muscle twitching
• Loss of consciousness
• Seizures
• Respiratory arrest
• Cardiac arrhythmias
• Ventricular arrest

Treatment of toxicity 9:

1. Stop administration immediately
2. Ventilate with 100% oxygen
3. Manage seizures with benzodiazepines (avoid propofol if cardiovascular instability)
4. Administer 20% lipid emulsion: 1.5 mL/kg bolus over 1 minute
5. Start lipid infusion at 0.25 mL/kg/min
6. Alert nearest facility with cardiopulmonary bypass capability

Critical Contraindications

Absolute contraindications:

• Complete heart block 5
• Known hypersensitivity to amide local anesthetics 10

Relative contraindications requiring dose adjustment:

• Concurrent use with other local anesthetics (wait 4 hours between regional blocks and IV lidocaine) 1
• Severe hepatic impairment 10
• Severe cardiovascular disease 10

Practical Implementation

Preparation:

• Calculate dose using ideal body weight
• Prepare resuscitation equipment and lipid emulsion
• Establish reliable IV access
• Ensure monitoring equipment is functional

Administration:

• Dilute to appropriate concentration
• Begin infusion 3 minutes before planned intubation
• Monitor continuously throughout
• Have assistant dedicated to hemodynamic monitoring

This protocol balances efficacy in blunting intubation responses against safety concerns, with the 1.5 mg/kg dose at 1-3 minutes providing optimal benefit-to-risk ratio for most patients 1, 2, 3, 6, 4.